rxstat › Shortages › Afatinib

Afatinib (Giotrif) shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Jul 9, 2026

A shortage of Afatinib is anticipated but not yet confirmed. 4 product(s) have anticipated-shortage reports on file with Health Canada.

A targeted therapy used to treat certain types of lung cancer.

Products affected
0 / 4
Reports on file
7

Reports by product

The DIN is printed on your prescription label.

Anticipated
GIOTRIF
40MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02415682
Anticipated
GIOTRIF
30MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02415674
Anticipated
GIOTRIF
20MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02415666
Anticipated
SANDOZ AFATINIB
20MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02512777 · Delay in shipping of the drug.
To be discontinued
GIOTRIF
30MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02415674
To be discontinued
GIOTRIF
40MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02415682
To be discontinued
GIOTRIF
20MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02415666

What's happening

A manufacturer has told Health Canada it expects supply of Afatinib to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Recent changes

Common questions

What is Afatinib used for?

A targeted therapy used to treat certain types of lung cancer.

When will Afatinib be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Afatinib in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Capmatinib (Tabrecta) No current shortage Larotrectinib (Vitrakvi) No current shortage Dasatinib (Sprycel) Partial shortage 1 of 14 reported products affected Everolimus (Afinitor) Partial shortage 1 of 11 reported products affected Gefitinib Partial shortage 1 of 4 reported products affected · est. return Dec 31, 2026 Sunitinib (Sutent) Partial shortage 2 of 9 reported products affected · est. return Aug 31, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.